Healthcare provider profile · identity verified

Robert H Stewart, MD

Family Practice · EMPORIA, KS · NPI 1356371876

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	587	127
Levothyroxine Sodium	Levothyroxine Sodium	562	110
Omeprazole	Omeprazole	294	66
Amlodipine Besylate	Amlodipine Besylate	275	70
Lisinopril	Lisinopril	260	67
Pantoprazole Sodium	Pantoprazole Sodium	246	66
Losartan Potassium	Losartan Potassium	233	61
Hydrochlorothiazide	Hydrochlorothiazide	205	41
Simvastatin	Simvastatin	186	36
Eliquis	Apixaban	177	22
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	148	26
Trazodone Hcl	Trazodone Hcl	133	33
Tamsulosin Hcl	Tamsulosin Hcl	132	30
Pravastatin Sodium	Pravastatin Sodium	130	31
Escitalopram Oxalate	Escitalopram Oxalate	129	27
Duloxetine Hcl	Duloxetine Hcl	122	25
Furosemide	Furosemide	121	30
Gabapentin	Gabapentin	117	30
Metoprolol Succinate	Metoprolol Succinate	116	28
Citalopram Hbr	Citalopram Hydrobromide	113	20
Atenolol	Atenolol	110	27
Metoprolol Tartrate	Metoprolol Tartrate	108	23
Rosuvastatin Calcium	Rosuvastatin Calcium	108	25
Allopurinol	Allopurinol	103	23
Enalapril Maleate	Enalapril Maleate	95	19
Tramadol Hcl	Tramadol Hcl	95	20
Montelukast Sodium	Montelukast Sodium	93	19
Metformin Hcl Er	Metformin Hcl	92	19
Potassium Chloride	Potassium Chloride	92	23
Alendronate Sodium	Alendronate Sodium	91	22
Carvedilol	Carvedilol	85	23
Oxybutynin Chloride Er	Oxybutynin Chloride	79	20
Albuterol Sulfate Hfa	Albuterol Sulfate	77	32
Celecoxib	Celecoxib	77	19
Ezetimibe	Ezetimibe	69	14
Metformin Hcl	Metformin Hcl	69	14
Donepezil Hcl	Donepezil Hcl	68	16
Spironolactone	Spironolactone	63	14
Sertraline Hcl	Sertraline Hcl	62	15
Warfarin Sodium	Warfarin Sodium	56	suppressed
Jardiance	Empagliflozin	55	suppressed
Azithromycin	Azithromycin	53	48
Clopidogrel	Clopidogrel Bisulfate	51	13
Finasteride	Finasteride	49	suppressed
Prednisone	Prednisone	49	33
Fluticasone Propionate	Fluticasone Propionate	45	20
Oxycontin	Oxycodone Hcl	45	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	43	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	40	11
Meloxicam	Meloxicam	38	13
Morphine Sulfate Er	Morphine Sulfate	38	suppressed
Rybelsus	Semaglutide	38	suppressed
Amoxicillin	Amoxicillin	37	29
Famotidine	Famotidine	36	suppressed
Glipizide	Glipizide	36	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	36	suppressed
Quetiapine Fumarate Er	Quetiapine Fumarate	36	suppressed
Topiramate	Topiramate	36	suppressed
Mirtazapine	Mirtazapine	34	suppressed
Tradjenta	Linagliptin	33	suppressed
Trulicity	Dulaglutide	32	suppressed
Raloxifene Hcl	Raloxifene Hcl	30	suppressed
Buspirone Hcl	Buspirone Hcl	29	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	29	suppressed
Alprazolam	Alprazolam	28	suppressed
Breo Ellipta	Fluticasone/Vilanterol	28	suppressed
Cephalexin	Cephalexin	28	13
Ozempic	Semaglutide	28	suppressed
Ropinirole Hcl	Ropinirole Hcl	28	suppressed
Baclofen	Baclofen	27	suppressed
Oxycodone Hcl	Oxycodone Hcl	27	suppressed
Enulose	Lactulose	26	suppressed
Pregabalin	Pregabalin	26	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	26	suppressed
Nystatin	Nystatin	25	14
Clonidine Hcl	Clonidine Hcl	23	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	23	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	23	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	22	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	21	suppressed
Colestipol Hcl	Colestipol Hcl	20	suppressed
Diclofenac Sodium	Diclofenac Sodium	20	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	20	suppressed
Januvia	Sitagliptin Phosphate	20	suppressed
Levetiracetam	Levetiracetam	20	suppressed
Lovastatin	Lovastatin	20	suppressed
Memantine Hcl	Memantine Hcl	20	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	20	18
Acetaminophen-Codeine	Acetaminophen With Codeine	19	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	19	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	19	17
Glipizide Er	Glipizide	19	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	19	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	18	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	17	suppressed
Breyna	Budesonide/Formoterol Fumarate	16	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	16	suppressed
Methadone Hcl	Methadone Hcl	16	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	15	suppressed
Cefdinir	Cefdinir	15	12
Clonazepam	Clonazepam	14	suppressed
Lactulose	Lactulose	14	suppressed
Roflumilast	Roflumilast	14	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	14	suppressed
Sucralfate	Sucralfate	14	suppressed
Tizanidine Hcl	Tizanidine Hcl	14	suppressed
Benztropine Mesylate	Benztropine Mesylate	13	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	13	suppressed
Diazepam	Diazepam	13	suppressed
Entresto	Sacubitril/Valsartan	13	suppressed
Nifedipine Er	Nifedipine	13	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	13	12
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	13	suppressed
Primidone	Primidone	13	suppressed
Temazepam	Temazepam	13	suppressed
Divalproex Sodium	Divalproex Sodium	12	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	12	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	12	suppressed
Lorazepam	Lorazepam	12	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	12	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	12	suppressed
Risperidone	Risperidone	12	suppressed
Telmisartan	Telmisartan	12	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	11	suppressed
Glimepiride	Glimepiride	11	suppressed
Naproxen	Naproxen	11	suppressed
Spiriva Handihaler	Tiotropium Bromide	11	suppressed
Tresiba Flextouch U-200	Insulin Degludec	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error